Alzheimer's research is at the forefront of understanding how the brain's immune system, particularly microglial cells, plays a crucial role in combating neurodegenerative diseases.These cells are not just immune sentinels; they actively prune synapses to maintain healthy brain function.
In a groundbreaking shift for Alzheimer's treatment, TIM-3 therapy for Alzheimer's emerges as a promising approach leveraging the body's immune response.Recent research indicates that by targeting the TIM-3 checkpoint molecule, it may be possible to unleash the brain's microglia to combat the harmful amyloid plaques associated with the disease.